PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.02%
Positive revenue growth while MAXN is negative. John Neff might see a notable competitive edge here.
19.50%
Gross profit growth under 50% of MAXN's 73.39%. Michael Burry would be concerned about a severe competitive disadvantage.
47.10%
EBIT growth 50-75% of MAXN's 71.83%. Martin Whitman would suspect suboptimal resource allocation.
47.10%
Operating income growth at 50-75% of MAXN's 66.50%. Martin Whitman would doubt the firm’s ability to compete efficiently.
18.20%
Net income growth under 50% of MAXN's 73.10%. Michael Burry would suspect the firm is falling well behind a key competitor.
14.29%
EPS growth of 14.29% while MAXN is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
23.08%
Diluted EPS growth under 50% of MAXN's 73.09%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-4.47%
Share reduction while MAXN is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-6.70%
Reduced diluted shares while MAXN is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-740.28%
Negative OCF growth while MAXN is at 93.92%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-250.83%
Negative FCF growth while MAXN is at 91.23%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
1309.36%
Positive 10Y revenue/share CAGR while MAXN is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
1309.36%
Positive 5Y CAGR while MAXN is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
1309.36%
3Y revenue/share CAGR above 1.5x MAXN's 7.06%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-2660.50%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-2660.50%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-2660.50%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
220.80%
Positive 10Y CAGR while MAXN is negative. John Neff might see a substantial advantage in bottom-line trajectory.
220.80%
Positive 5Y CAGR while MAXN is negative. John Neff might view this as a strong mid-term relative advantage.
220.80%
Positive short-term CAGR while MAXN is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.44%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-12.62%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.21%
Positive asset growth while MAXN is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
7.35%
Positive BV/share change while MAXN is negative. John Neff sees a clear edge over a competitor losing equity.
No Data
No Data available this quarter, please select a different quarter.
1.10%
R&D dropping or stable vs. MAXN's 3.39%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-1.63%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.